SoundThinking, Iovance, and WidePoint Shares Surge on Acquisition and Contract News

Key Facts

1SoundThinking shares surged 50.09% after Transom Capital Group agreed to take the company private in a cash deal.

2Iovance Biotherapeutics rose 31.48% after raising its 2026 revenue guidance due to strong demand for its cancer drug Amtagvi.

3WidePoint shares gained 24.58% following an update regarding a Department of Homeland Security contract decision.

SoundThinking shares surged 50.09% to $8.21 after Transom Capital Group agreed to take the company private in a cash deal. The Wall Street Journal reported that the agreement includes $8.00 per share in cash, along with potential additional value through contingent rights.

Iovance Biotherapeutics rose 31.48% to $14.45 after raising its 2026 revenue guidance, with Barron's noting that strong demand for its cancer drug Amtagvi served as a key growth driver. Additionally, WidePoint shares gained 24.58% to close at $7.35 following an update regarding a Department of Homeland Security contract decision.

In previous trading, IOVA closed at $10.99, SSTI at $5.47, and WYY at $5.90 on September 28, 2026. These significant price movements reflect specific corporate catalysts including M&A activity, revised financial outlooks, and federal government contract developments.